Blood Eosinophil Count Predicts Treatment Failure and Hospital Readmission for COPD
| dc.contributor.author | Kerkhof, Marjan | |
| dc.contributor.author | Chaudhry, Isha | |
| dc.contributor.author | Pavord, Ian D. | |
| dc.contributor.author | Miravitlles, Marc | |
| dc.contributor.author | Rhee, Chin Kook | |
| dc.contributor.author | Halpin, David M.G. | |
| dc.contributor.author | Usmani, Omar S. | |
| dc.contributor.author | Jones, Rupert | |
| dc.contributor.author | Kocks, Janwillem | |
| dc.contributor.author | Alacqua, Marianna | |
| dc.contributor.author | Morris, Tamsin | |
| dc.contributor.author | Kaplan, Alan | |
| dc.contributor.author | Price, David B. | |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.date.accessioned | 2020-11-19T12:09:01Z | |
| dc.date.available | 2020-11-19T12:09:01Z | |
| dc.date.issued | 2020 | |
| dc.description | ACKNOWLEDGEMENTS This study was funded by AstraZeneca. Editorial support was provided by Joanne M. Faysal, MS, and Jennie G. Jacobson, PhD, CMPP, of JK Associates, Inc., and Michael A. Nissen, ELS, of AstraZeneca. This support was funded by AstraZeneca. DATA-SHARING STATEMENT Data underlying the findings described in this manuscript may be requested in accordance with AstraZeneca’s data-sharing policy described at https://astrazenecagroupdt.pharmacm.com/DT/Home | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 12 | |
| dc.format.extent | 867471 | |
| dc.identifier | 174753742 | |
| dc.identifier | caf634c8-867d-457f-a7f7-dde77f87ba12 | |
| dc.identifier | 33693048 | |
| dc.identifier | 85108579660 | |
| dc.identifier.citation | Kerkhof, M, Chaudhry, I, Pavord, I D, Miravitlles, M, Rhee, C K, Halpin, D M G, Usmani, O S, Jones, R, Kocks, J, Alacqua, M, Morris, T, Kaplan, A & Price, D B 2020, 'Blood Eosinophil Count Predicts Treatment Failure and Hospital Readmission for COPD', ERJ Open Research, vol. 6, no. 4. https://doi.org/10.1183/23120541.00188-2020 | en |
| dc.identifier.doi | 10.1183/23120541.00188-2020 | |
| dc.identifier.iss | 4 | en |
| dc.identifier.issn | 2312-0541 | |
| dc.identifier.uri | https://hdl.handle.net/2164/15384 | |
| dc.identifier.vol | 6 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | ERJ Open Research | en |
| dc.subject | COPD | en |
| dc.subject | eosinophils | en |
| dc.subject | hospitalisation | en |
| dc.subject | COPD treatment | en |
| dc.subject | Exacerbations | en |
| dc.subject | R Medicine (General) | en |
| dc.subject.lcc | R1 | en |
| dc.title | Blood Eosinophil Count Predicts Treatment Failure and Hospital Readmission for COPD | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Kerkhof_et_al_ERJOpen_BloodEosinophilCountPredicts_VoR.pdf
- Size:
- 847.14 KB
- Format:
- Adobe Portable Document Format
